Cubist Systematic Strategies, LLC 2seventy Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.21 - $14.98 $34,021 - $55,336	3,694 Added 896.6%	4,106 $41,000
Q4 2022 Feb 14, 2023	SELL	$8.57 - $17.0 $208,225 - $413,049	-24,297 Reduced 98.33%	412 $3,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $297,194 - $415,031	23,662 Added 2259.98%	24,709 $360,000
Q2 2022 Aug 15, 2022	SELL	$10.55 - $18.81 $24,824 - $44,259	-2,353 Reduced 69.21%	1,047 $14,000
Q1 2022 May 16, 2022	BUY	$11.67 - $26.72 $15,451 - $35,377	1,324 Added 63.78%	3,400 $58,000
Q4 2021 Feb 14, 2022	BUY	$13.77 - $42.56 $28,586 - $88,354	2,076 New	2,076 $53,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.